ArticlePloS one2020

First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials.

Wei Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.